BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Terason Announces Agreement with SenoRx, Inc. (SENO) to Provide Its Portable Laptop t3000 Ultrasound System for the Launch of a New SenoSonix(TM) Model


4/16/2009 10:50:30 AM

BURLINGTON, Mass.--(BUSINESS WIRE)--Terason, the market leading producer of high performance Laptop Ultrasound™ imaging systems today announced that it has reached an agreement with SenoRx, Inc. (NASDAQ: SENO) to provide its Terason t3000 ultrasound for the launch of an additional model of the SenoSonix™ System. Like the original SenoSonix, the new model is an integration of SenoRx’s EnCor® breast biopsy system with ultrasound imaging. This new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility designed, developed and marketed by Terason. This versatile ultrasound technology coupled with SenoRx’s proprietary EnCor vacuum-assisted biopsy technology results in an attractive alternative model of the SenoSonix System for customers. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability. The original SenoSonix System received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October 2007 and CE Mark approval in April 2008.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES